Voluntary Recall of Iliadin® Solution 0.025%, Iliadin® Solution 0.05%, Iliadin® Spray 0.05%, Iliadin® Solution for Nose 0.01%
Healthcare professional
Therapeutic Products
4 February 2013
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Merck would like to inform healthcare professionals of the voluntary recall of selected batches of Iliadin® Solution 0.025%, Iliadin® Solution 0.05%, Iliadin® Spray 0.05% and Iliadin® Solution for Nose 0.01% due to isolated instances of microbiological impurities being identified near the end of the products' shelf life or upon expiry. During routine testing, isolated instances of microbiological impurities were identified in a few batches of Iliadin products manufactured before June 2012. A review of the manufacturing and steaming operation of the filling tank had identified the source of microbial impurities to be purified water used for chilling of the filling tank, of which a possible back flow into the filling tank may have resulted in the contamination. As a precautionary measure, Merck is initiating an immediate voluntary recall of all batches of Iliadin® Solution 0.025%, Iliadin® Solution 0.05%, Iliadin® Spray 0.05% and Iliadin® Solution for Nose 0.01% manufactured before June 2012. Healthcare professionals are advised to refer to the Dear Healthcare Professional Letter for further details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
